Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. EVLV
EVLV logo

EVLV Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Evolv Technologies Holdings Inc (EVLV) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
7.200
1 Day change
2.42%
52 Week Range
8.910
Analysis Updated At
2026/04/24
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Evolv Technologies Holdings Inc (EVLV) is not a strong buy at the moment for a beginner investor with a long-term strategy. While the company has shown revenue growth in its latest quarter, the decline in net income, EPS, and gross margin raises concerns about profitability. Additionally, the stock's technical indicators are neutral, and there are no strong proprietary trading signals or significant positive catalysts to justify immediate investment.

Technical Analysis

The MACD histogram is positive but contracting, RSI is neutral at 53.835, and moving averages are converging, indicating no clear trend. The stock is trading near its pivot level of 6.359, with resistance at 6.798 and support at 5.921.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
5
Buy
11

Positive Catalysts

  • The company reported a 32% YoY revenue increase in Q4 2025, transitioning from a net loss to a net income of $10.9 million.

Neutral/Negative Catalysts

  • The co-founder recently sold shares, reducing his holdings by 3.73%. Gross margin, EPS, and net income have declined significantly YoY. No recent congress trading data or strong hedge fund/insider activity.

Financial Performance

In Q4 2025, revenue grew by 32% YoY to $38.5 million, but net income dropped by 169.22% YoY to $10.9 million. EPS declined by 160% YoY to 0.06, and gross margin fell by 15.9% to 48.38%.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No recent analyst rating or price target changes available for analysis.

Wall Street analysts forecast EVLV stock price to rise
4 Analyst Rating
Wall Street analysts forecast EVLV stock price to rise
4 Buy
0 Hold
0 Sell
Strong Buy
Current: 7.200
sliders
Low
9.5
Averages
9.83
High
10
Current: 7.200
sliders
Low
9.5
Averages
9.83
High
10
Lake Street
Eric Martinuzzi
Buy
maintain
$9 -> $10
AI Analysis
2025-11-14
Reason
Lake Street
Eric Martinuzzi
Price Target
$9 -> $10
AI Analysis
2025-11-14
maintain
Buy
Reason
Lake Street analyst Eric Martinuzzi raised the firm's price target on Evolv to $10 from $9 and keeps a Buy rating on the shares. Q3 beat "by a mile," says the analyst, who sees 2026 as "a breakout year" in which ARR growth will exceed revenue growth.
TD Cowen
NULL
to
Buy
initiated
$10
2025-08-15
Reason
TD Cowen
Price Target
$10
2025-08-15
initiated
NULL
to
Buy
Reason
TD Cowen reinstated coverage of Evolv with a Buy rating and $10 price target. Under new management, the company's statements have been completed and its regulatory overhangs have "gradually diminished." the analyst tells investors in a research note. The firm says Evolv reported "healthy" Q2 results and raised its fiscal 2025 revenue outlook as it sees momentum across major verticals.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for EVLV
Unlock Now

People Also Watch